ORGANIZATION

Eli Lilly and Company

corporation

13LDA FILINGS
56LOBBYISTS
0FLY-INS

Federal Lobbying Spend

$4.6M

Total LDA-disclosed spend (in-house + retained) across all reported periods.

Most recent LDA filing posted April 2026.

Topics in Filings

43

Policy topics named in LD-2 filings. This org's filings are topical rather than positional — these are the issues it's actively lobbying on, even without a stated verb of position.

SAFE Drugs Act×8
Affordable Prescriptions for Patients Act×6
Alzheimer's Disease×6
Anti Obesity Medication×6
Medicare/Medicaid Coverage and Reimbursement×6
PDUFA. 340B Program×6
Preserve Access to Affordable Generics and Biosimilars Act×6
Safeguarding Americans from Fraudulent and Experimental×6
340B Program×4
Drug Shortage Compounding Patient Access Act×4
Engagement relates to issues×4
Intellectual property×4
Show all 43 topics (+31 more) ▾
Supply chain management×4
There is no specific bill filed×4
Treat and Reduce Obesity Act×4
Canada IP×2
CMS National Coverage Determination on Alzheimer's disease×2
Diagnostic tests Clinical trial issues×2
Domestic manufacturing tax incentives×2
Drug importation×2
Drug pricing, coverage, value, access and quality×2
Expensing of research and development costs×2
Federal budget issues×2
Global minimum tax×2
Health insurance accessibility×2
Hospital discounts×2
Medicare & Medicaid payment and coverage issues×2
Medicare Part B, drug pricing in federal programs×2
Medicare Part D×2
Mexico patent linkage×2
Multi-lateral threats to IP and the biopharmaceutical industry×2
Patient protection×2
Pension and retirement benefit issues×2
Pharmaceutical intellectual property issues×2
Pharmaceutical supply chain issues×2
Pharmaceutical tariffs Safe Drugs Act×2
Prescription drug approval×2
Prescription drug value, access and quality×2
Special 301×2
Trade talks: US-Japan×2
US Tariffs×2
US-India, and US-Brazil×2
USMCA implementation×2

Bills in Play

8

Bills referenced in this org's LD-2 filing text. Frequency = how many activities reference each.

H.R. 6509

10 mentions

S. 1041

6 mentions

S. 1096

6 mentions

H.R. 5376

4 mentions

H.R. 5316

4 mentions

S. 3794

4 mentions

H.R. 4231

2 mentions

S. 1973

2 mentions

Lobbyists on Record

56
BRANDT ANDERSON · Brownstein Hyatt Farber Schreck, LLPformer Research Assistant, House Committee on Veterans…
CRISTINA ANTELO · Ferox Strategiesformer Legal Fellow, Senate Democratic Steering Commit…
ERIC BERGREN · Todd Strategy Groupformer Chief of Staff, Rep. Brett Guthrie; Staff Assis…
PARICK CARROLL · Tarplin, Downs & Young, LLCformer Leg Asst. Rep. Ray LaHood, Leg Dir. Rep. Kevin …
KATHERINE COTTON · Todd Strategy Groupformer Staff Assistant, Legislative Correspondent, Leg…
DEBRA DIXON · Ferox Strategiesformer Chief of staff to Rep. Xavier Becerra, legislat…
RAISSA DOWNS · Tarplin, Downs & Young, LLCformer Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst…
KRISTINA DUNKLIN · Forbes-tateformer Legislative Director, Rep. Susan Brooks (2018-2…
PAUL EDATTEL · Todd Strategy Groupformer Chief Health Counsel, House Energy & Commerce C…
KIMBERLY ELLIS · Monument Advocacyformer Legislative Director, Rep. Kevin Brady (R-TX); …
PETER FISE · Tarplin, Downs & Young, LLCformer Health Counsel for Sen. Cmte on Finance, Health…
JOHN GONZALEZ · Tiber Creek Groupformer Chief of Staff, Rep. Melissa Bean (2005-2009); …

+ 44 more lobbyists on record